Histiocytosis X.
To clarify salient issues pertaining to histiocytosis X--a syndrome that includes Letterer-Siwe disease, Hand-Schuller-Christian disease, and eosinophilic granuloma--the authors review the epidemiologic data and the histologic, morphologic, and clinical bases for diagnosis and prognosis. Histiocytes are defined and their possible histogenesis outlined, and Langerhans cells, which may be a leading element in active lesions, are characterized. The authors outline hypothetic pathogenetic schema, which they recommend be tested by recently developed immunologic and genetic means, since histiocytosis X, at least in its disseminated form, remains an unpredictable disease for which there is no proven effective therapy.
D000293:Adolescent; D000818:Animals; D001847:Bone Diseases / Q000473:pathology; D001855:Bone Marrow Diseases / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D004803:Eosinophilic Granuloma / Q000473:pathology*; D005260:Female; D006644:Histiocytes / Q000276:immunology / Q000473:pathology; D006646:Histiocytosis, Langerhans-Cell / Q000453:epidemiology / Q000473:pathology*; D006801:Humans; D007223:Infant; D007801:Langerhans Cells / Q000276:immunology / Q000648:ultrastructure; D008107:Liver Diseases / Q000473:pathology; D008171:Lung Diseases / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D011379:Prognosis; D012871:Skin Diseases / Q000473:pathology; D013577:Syndrome; D013950:Thymus Gland / Q000473:pathology; D014481:United States